Staritas

Based in the US, Staritas offers data-driven healthcare supply chain analytics and advisory services to enhance operational efficiency and decision-making for healthcare organizations. Staritas, founded in 2026 and headquartered in Boston, US, specializes in healthcare supply chain analytics. The company was acquired by Accel-KKR from ECRI in April 2026, enabling it to operate independently. The founder's specific history is not documented.

Staritas specializes in providing advanced spend and recall management solutions tailored for healthcare organizations. Their core offerings include a comprehensive Supply and Capital Dataset, Functional Equivalents, Utilization Analytics, Recall Management, and Value Analysis Workflow. These products are designed to enhance transparency and decision-making within the healthcare supply chain by delivering data-driven insights and analytics. For instance, their benchmarking tools enable healthcare providers to identify cost-saving opportunities and negotiate better pricing by utilizing an independent assessment of market rates.

Staritas serves a diverse client base that includes nearly 90% of top U. S. hospitals and healthcare systems, focusing primarily on the North American market, but also extending their services to international clients seeking improved supply chain management and operational efficiency. The company's solutions address critical challenges such as opaque pricing, supply chain disruptions, and the need for standardized products, ultimately aiming to enhance patient care and operational performance.

Staritas generates revenue through a B2B model, primarily by providing subscription-based access to its analytics and management solutions. Clients typically engage in contractual agreements that grant them access to the various products, allowing for consistent updates and support. Transactions may involve tiered pricing plans based on the scale of services utilized, ensuring that organizations can tailor their engagement to meet their specific needs. Flagship products like Supply Navigator™ and SurgiSmartIQ™ form the backbone of the company’s revenue stream, facilitating strategic purchasing and utilization decisions.

The transaction structure is designed to foster long-term partnerships, enabling healthcare providers to continuously benefit from Staritas's evolving analytics capabilities and insights, thereby enhancing their overall operational effectiveness and cost management strategies. Following its acquisition in April 2026, Staritas plans to expand its healthcare supply chain analytics and advisory services. The company aims to develop and launch new products to enhance its offerings further, while focusing on expanding into international markets. The recent acquisition will provide the necessary resources to support these initiatives and facilitate independent operations aimed at scaling their services.